20 new drugs to be commercialized soon
The Korea Drug Research Association said that clinical trials are under way for 20 news drugs being developed by domestic pharmaceutical firm, except for SK Chemical's Sunpla inj. (antineoplastic), Daewoong's EGF solution (diabetic ulcer treatment), and Dongwha's Milican inj. (antihepatic...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
